MotherToBaby

Medications and More during pregnancy and breastfeeding

Search

866.626.6847

Abatacept

Selected References

  • Bristol-Myers Squibb. 2019. Available information online at https://clinicaltrials.gov/ct2/show/record/NCT01087125?view=record
  • Squibb and Sons, L.L.C. 2019. Orencia product lab. Available at https://dailymed.nlm.nih.gov/dailymed/druginfo.cfm?setid=0836c6ac-ee37-5640-2fed-a3185a0b16eb
  • Kumar M, et al. 2015. Pregnancy outcomes following exposure to abatacept during pregnancy. Semin Arthritis Rheum, 45(3):351-356.
  • Makol A, et al. 2011. Rheumatoid arthritis and pregnancy: safety considerations in pharmacological management. Drugs, 71(15):1973-1987.
  • Ojeda-Uribe M, et al. 2013. Exposure to abatacept or rituximab in the first trimester of pregnancy in three women with autoimmune diseases. Clin Rheumatol, 32(5):695-700.
  • Ostensen M and Förger F. 2011. Treatment with biologics of pregnant patients with rheumatic diseases. Curr Opin Rheumatol, 23(3):293-298.
  • Partlett R and Roussou E. 2011. The treatment of rheumatoid arthritis during pregnancy. Rheumatol Int, 31(4):445-449.
  • Pham T., et al. 2012. Abatacept therapy and safety management. Joint Bone Spine, 79 Suppl 1:3-84.

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $6,000,000 with zero percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, HRSA, HHS, or the U.S. Government.